Oligometastatic Squamous Cell Carcinoma of the Head and Neck
1 clinical trials · Condition
◉ Watch Oligometastatic Squamous Cell Carcinoma of the Head and Neck
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer (NCT05815927) | European Organisation for Research and Treatment of Cancer - EORTC | 2025-05-23 |
Track Oligometastatic Squamous Cell Carcinoma of the Head and Neck automatically
Every clearance here is in the API, with alerts when new ones post.